Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

Share Price is delayed by 15 minutes
Get Live Data
200.00    0.00 (0.00%)
Bid:
195.00
Ask:
205.00
Spread: 10.00 (5.128%)
Market Cap: £34.01m
SNX Live PriceLast checked at - London Stock Exchange

Intraday Synectics Share Chart

Director/PDMR Shareholding

4 Apr 2023 08:09

RNS Number : 2929V
Synectics PLC
04 April 2023
Β 

Β 

Β 

RNS

Β 

4 April 2023

Β 

Β 

Synectics plc

("Synectics" or the "Company")

Β 

Director dealings

Β 

Synectics plc (AIM: SNX), a leader in advanced security and surveillance systems, has been notified that on 3 April 2023, the Trustee of the Company's HMRC Approved Employee Share Acquisition Plan ("ESAP") purchased a total of 13,369 ordinary shares of 20 pence each in the Company ("Ordinary Shares") at a price of Β£1.15 per share in accordance with the ESAP's rules and on behalf of all ESAP participants, in respect of the six-month accumulation period ended on 31 March 2023.

Β 

Under the terms of the ESAP, participating members, including employees and an executive Director of the Company, contribute a fixed amount to the Trustee on a monthly basis. The Trustee acquires a number of shares at the end of the six-month accumulation period (the "Period") based upon the contributions made in the Period and determined by the lowest share price at either the beginning of the Period or on the date of purchase. In this instance, the share price used for the allocation of the number of shares for ESAP purposes was the price per share at the beginning of the Period which was Β£1.05.

Β 

As a result of this purchase, the Company has been notified that the following Director has acquired the following interests in Ordinary Shares:

Β 

Β 

Β 

Name

Β 

Β 

Position

Number of Ordinary Shares Purchased by the Trustee

Paul Webb

Chief Executive

857

Β 

Following this purchase, the interests of Mr Webb in Ordinary Shares are as follows:

Β 

Name

Β 

Number of Ordinary Shares Held

Interest in Ordinary Shares in Share Schemes

Β 

Β 

Resultant Total Interest

Β 

Β 

% of Issued Share Capital

Paul Webb

57,115

514,033

571,148

3.21

Β 

For further information, please contact:

Synectics plc

Claire Stewart, Company Secretary

email: info@synecticsplc.com

Tel: +44 (0) 114 280 2828

www.synecticsplc.com

Β 

Β 

Shore Capital

Β 

Tom Griffiths / David Coaten

Tel: +44 (0) 20 7408 4090

Β 

About Synectics plc

Β 

Synectics (AIM: SNX) is a leader in advanced security and surveillance systems that help protect people, property, communities, and assets around the world.

Β 

The Company's expertise is in providing solutions for specific markets where security and surveillance are critical to operations. These include gaming, oil and gas, public space, transport, and critical infrastructure.

Β 

Synectics has deep industry experience in these markets and works closely with customers to deliver solutions that are tailored to meet their needs. Technical excellence, combined with decades of experience and long-standing customer relationships, provides fundamental differentiation from mainstream suppliers and makes the Company a stand-out in its field.

Β 

Find out more at www.synecticsplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHIIMRTMTMMMAJ
Date   Source Headline
13th Jun 20077:01 amRNSPreliminary Results
24th May 20074:24 pmRNSNotice of Results
8th Mar 20077:00 amRNSHolding(s) in Company
20th Feb 200712:33 pmRNSGrant of Options
7th Feb 20077:02 amRNSNorth American Contract Wins
7th Feb 20077:02 amRNSInterim Results
6th Feb 200710:14 amRNSDirector/PDMR Shareholding
5th Feb 20077:00 amRNSDirectorate Change
29th Jan 20072:58 pmRNSNotice of Results
26th Jan 20077:01 amRNSTrading Update
28th Dec 20064:36 pmRNSGrant of Options
22nd Dec 20069:37 amRNSTotal Voting Rights & Capital
5th Dec 20067:01 amRNSInterim Results
29th Nov 20063:25 pmRNSDirector/PDMR Shareholding
24th Nov 200611:53 amRNSNotice of Results
24th Oct 20067:01 amRNSAcquisition
4th Oct 20067:00 amRNSTrading Statement
18th Sep 20069:11 amRNSDirectorate Change
13th Jul 20067:01 amRNSIssue of Equity
20th Jun 200610:39 amRNSGrant of Options
14th Jun 20065:06 pmRNSIssue of Equity
6th Jun 20067:03 amRNSFinal Results
6th Jun 20067:02 amRNSAcquisition of DUH
6th Jun 20067:02 amRNSDirectorate Change
9th May 20062:31 pmRNSIssue of Equity
21st Apr 20062:15 pmRNSHolding(s) in Company
21st Apr 20067:00 amRNSContract Win
11th Apr 200612:19 pmRNSIssue of Equity
10th Apr 20067:01 amRNSPre-Close Statement
6th Apr 200612:39 pmRNSHolding(s) in Company
30th Mar 20062:30 pmRNSHolding(s) in Company
29th Mar 20063:28 pmRNSHolding(s) in Company
24th Mar 20065:39 pmRNSIssue of Equity
22nd Mar 20065:03 pmRNSDirector/PDMR Shareholding
21st Mar 20064:34 pmRNSIssue of Equity
14th Mar 200610:23 amRNSIssue of Equity
6th Mar 20066:00 pmRNSIssue of Equity
6th Mar 20064:01 pmRNSHolding(s) in Company
28th Feb 20061:34 pmRNSHolding(s) in Company
24th Feb 20064:51 pmRNSHolding(s) in Company
23rd Feb 20065:57 pmRNSIssue of Equity
22nd Feb 20064:21 pmRNSHolding(s) in Company
6th Feb 200610:38 amRNSIssue of Equity
31st Jan 20068:00 amRNSAcquisition
27th Jan 20064:48 pmRNSIssue of Equity
27th Jan 20064:45 pmRNSOffer Update
13th Jan 20065:02 pmRNSIssue of Equity
9th Jan 200612:14 pmRNSIssue of Equity
3rd Jan 20065:28 pmRNSIssue of Equity
20th Dec 20054:32 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.